Journal of Gastrointestinal Cancer
Scope & Guideline
Advancing knowledge in the battle against gastrointestinal cancer.
Introduction
Aims and Scopes
- Clinical Research and Trials:
The journal emphasizes original clinical research, including randomized controlled trials, cohort studies, and case-control studies that evaluate novel treatments, surgical techniques, and patient outcomes in gastrointestinal cancers. - Molecular and Genetic Studies:
Research focusing on the molecular mechanisms underlying gastrointestinal cancers, including studies on genetic mutations, biomarkers, and their implications for diagnosis, prognosis, and targeted therapies. - Epidemiology and Public Health:
The journal publishes epidemiological studies that explore the incidence, prevalence, risk factors, and survival rates of gastrointestinal cancers, contributing valuable data to public health discussions. - Interdisciplinary Approaches:
Recognizing the complexity of cancer treatment, the journal encourages interdisciplinary studies that integrate surgical, medical, and palliative care perspectives in the management of gastrointestinal cancers. - Innovative Therapies and Technologies:
The journal highlights research on innovative therapeutic approaches, including immunotherapy, targeted therapy, and novel surgical techniques, as well as advancements in diagnostic technologies.
Trending and Emerging
- Immunotherapy and Biomarkers:
A significant increase in research related to immunotherapy, including studies on PD-1/PD-L1 inhibitors and their associated biomarkers, indicates a growing focus on personalized cancer treatments. - Microbiome and Cancer Interactions:
Research examining the role of the gut microbiome in gastrointestinal cancers has gained prominence, suggesting its potential impact on cancer pathogenesis and treatment responses. - Patient-Centered Care and Quality of Life:
There is an emerging emphasis on studies evaluating patient-reported outcomes, quality of life, and the psychosocial aspects of cancer care, reflecting a broader understanding of patient needs. - Integration of Artificial Intelligence in Oncology:
The use of artificial intelligence and machine learning in predicting treatment responses and outcomes is increasingly featured, highlighting the trend towards data-driven approaches in oncology. - Health Disparities and Access to Care:
Research focusing on health disparities related to gastrointestinal cancers, including socioeconomic factors and access to care, is becoming more prevalent, addressing equity in cancer treatment.
Declining or Waning
- Traditional Chemotherapy Studies:
There appears to be a decreasing trend in publications solely focused on traditional chemotherapy regimens, as more research is now directed towards personalized medicine and targeted therapies. - Basic Science and Preclinical Studies:
The journal has seen a reduction in the number of purely basic science studies, particularly those that do not translate into clinical applications, as the emphasis shifts towards clinical relevance. - Single-Institution Studies:
There is a noticeable decline in the number of studies originating from single institutions, with a preference for multicenter studies that provide broader data and enhance generalizability. - Conventional Imaging Techniques:
Research focusing on conventional imaging techniques has waned in favor of studies utilizing advanced imaging modalities like PET/CT and MRI, reflecting a shift towards precision diagnostics. - Epidemiological Studies in Non-Western Populations:
While there is still interest in epidemiological studies, there has been a decline in research specifically targeting non-Western populations, which may limit the global understanding of gastrointestinal cancer trends.
Similar Journals
Canadian Journal of Gastroenterology and Hepatology
Fostering Collaboration in Gastrointestinal and Liver StudiesCanadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.
Indian Journal of Gastroenterology
Bridging Research and Practice in Gastrointestinal HealthThe Indian Journal of Gastroenterology, a prominent publication in the field of gastroenterology, is published by Springer India. With roots dating back to 1982 and an ongoing commitment to disseminating high-quality research, this journal serves as a vital platform for researchers, practitioners, and students interested in gastrointestinal health and diseases. It boasts an impressive track record with a Scopus rank of #82 in the gastroenterology category and a 2023 quartile ranking of Q3, firmly situating it within the competitive landscape of medical journals. Although it is not an open-access journal, the Indian Journal of Gastroenterology offers accessible research articles contributing significantly to the field, facilitating informed discussion and advancing knowledge in gastrointestinal medicine. The journal's comprehensive focus covers a wide range of topics from clinical studies to innovative therapeutic approaches, ensuring its relevance to current medical practices and the evolving challenges in gastroenterology.
BMJ Open Gastroenterology
Elevating Patient Care with Open Access Gastroenterology ResearchBMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Exploring Innovations in Gastroenterology Since 1966SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.
ANTICANCER RESEARCH
Advancing the Frontiers of Cancer ResearchANTICANCER RESEARCH, published by the International Institute of Anticancer Research, stands at the forefront of cancer-related scholarly communication. With ISSN 0250-7005 and E-ISSN 1791-7530, this esteemed journal has been serving the global research community since 1981, showcasing innovative research aimed at combating cancer through various therapeutic approaches and scientific inquiry. Based in Greece, the journal aims to disseminate vital findings in the fields of Cancer Research, Medicine, and Oncology, reflecting its notable categorization in the Q3 and Q2 quartiles as of 2023. Despite its rigorous peer-review process and the absence of open access, ANTICANCER RESEARCH remains a vital publication for researchers, clinicians, and students eager to stay updated on the evolving landscape of anticancer strategies. As it converges to its milestone year of 2024, the journal continues to enrich the discourse around cancer treatment and prevention, affirming its position as an essential resource for those dedicated to advancing knowledge in anticancer therapies.
GUT
Advancing the Frontiers of Gastrointestinal ScienceGUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.
Gastroenterology Insights
Pioneering Research for Optimal Digestive WellnessGastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.
Gastroenterology Research
Delivering impactful research to the global gastroenterology community.Gastroenterology Research is a prominent scholarly journal dedicated to advancing the field of gastroenterology. Published by ELMER PRESS INC, this journal serves as a vital platform for disseminating innovative research, clinical findings, and comprehensive reviews that explore the complexities of the gastrointestinal system. With an ISSN of 1918-2805 and an E-ISSN of 1918-2813, it reaches a global audience of researchers, healthcare professionals, and students eager to contribute to or keep abreast of the latest developments in gastroenterology. Though details such as the H-index and Scopus rankings are currently unspecified, the journal's commitment to quality and impact in the medical research community is evident. Gastroenterology Research aims to foster collaboration and knowledge sharing among experts, ultimately improving patient care and outcomes within this critical area of health science. Explore the cutting-edge studies published within its pages and engage with a community passionate about the investigation and treatment of gastrointestinal diseases.
Gastrointestinal Tumors
Empowering Research for a Healthier TomorrowGastrointestinal Tumors is a reputable, peer-reviewed journal dedicated to advancing knowledge in the field of gastrointestinal oncology. Published by KARGER, this journal has been a pivotal platform since its transition to Open Access in 2014, ensuring that research findings are accessible to a global audience of researchers, clinicians, and students engaged in this vital area of study. With an emphasis on innovative research, clinical studies, and comprehensive reviews, Gastrointestinal Tumors aims to bridge gaps in knowledge and foster discussions that will inform and enhance clinical practices. The journal's commitment to excellence reflects the rising importance of gastrointestinal health in medical research, making it an essential resource for anyone seeking to stay at the forefront of this rapidly evolving field. Based in Basel, Switzerland, it is positioned within a strong academic community, and continues to influence the landscape of gastrointestinal cancer research.
Journal of Gastrointestinal Oncology
Uncovering breakthroughs in cancer management and care.The Journal of Gastrointestinal Oncology, published by AME Publishing Company, is a leading open-access journal that focuses on the complex interplay between gastroenterology and oncology. Established in 2012 and converging into a reputable academic platform through 2024, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and management of gastrointestinal cancers. With an ISSN of 2078-6891 and an E-ISSN of 2219-679X, this journal presents articles that are rigorously peer-reviewed, ensuring high-quality content that meets the demands of the scientific community. Despite its current categorization in the Q3 quartile for both Gastroenterology and Oncology as of 2023, it consistently strives to improve its impact and relevance, reflected in its Scopus rankings and percentile metrics. Publishing noteworthy research, reviews, and case studies, the Journal of Gastrointestinal Oncology is instrumental in addressing significant challenges in the field, making it a must-read for those dedicated to advancing knowledge and practice in gastrointestinal oncology.